#Samsung Biologics
(2nd LD) Samsung Biologics plans to set up holding company to separate CDMO, biosimilar biz
related article
(ATTN: ADDS Samsung Bioepis' comments in paras 12-14; UPDATES with closing price at bottom)
SEOUL, May 22 (Yonhap) -- Samsung Biologics Co., a biotech arm of South Korea's Samsung Group, said Thurs...
15:54 May. 22